As widely expected, the Drugs Controller General of India (DCGI) has granted approval for restricted use in an emergency situation to COVID-19 vaccine Covovax, Serum Institute of India Pvt. Ltd.’s version of partner Novavax, Inc.’s Nuvaxovid.
Coronavirus Update: India Approves Multiple New Vaccines
Plus, Wins And Losses For China Drug Developers
India has issued emergency approvals for a number of new vaccines and extended eligible age groups for others, while developers of potential drug therapies in China see both gains and setbacks.
